Yuji Eso
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
-
- Cancer Genomics and Diagnostics
Papers in
- Hepatology 29
- Hepatocellular Carcinoma Treatment and Prognosis 22
- Hepatitis C virus research 7
- Liver physiology and pathology 5
- Oncology 12
- Cancer Immunotherapy and Biomarkers 6
- Co-authors
- Hiroyuki Marusawa (29 shared papers)Hiroshi Seno (36 shared papers)Atsushi Takai (29 shared papers)Haruhiko Takeda (17 shared papers)Takahiro Shimizu (9 shared papers)Ken Takahashi (19 shared papers)Kojiro Taura (9 shared papers)Tsutomu Chiba (10 shared papers)
- Journals
- Hepatology Research (9 papers)Journal of Gastroenterology (5 papers)Journal of Gastroenterology and Hepatology (5 papers)Cancers (4 papers)Cancer Research (3 papers)
- Partner nations
- JapanUnited States
In The Last Decade
Yuji Eso
57 papers receiving 949 citations
Peers
Comparison fields: 5 of 67
- Hepatology 417
- Cancer Research 148
- Oncology 250
- Pathology and Forensic Medicine 109
- Epidemiology 185
Countries citing papers authored by Yuji Eso
This map shows the geographic impact of Yuji Eso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuji Eso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuji Eso more than expected).
Fields of papers citing papers by Yuji Eso
This network shows the impact of papers produced by Yuji Eso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuji Eso. The network helps show where Yuji Eso may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuji Eso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 144 | |
| 2 | 2020 | 70 | |
| 3 | 2011 | 69 | |
| 4 | 2018 | 68 | |
| 5 | 2017 | 56 | |
| 6 | 2020 | 50 | |
| 7 | 2011 | 47 | |
| 8 | 2021 | 44 | |
| 9 | 2013 | 37 | |
| 10 | 2016 | 31 | |
| 11 | 2019 | 24 | |
| 12 | 2015 | 23 | |
| 13 | 2016 | 22 | |
| 14 | 2019 | 22 | |
| 15 | 2020 | 22 | |
| 16 | 2020 | 21 | |
| 17 | 2011 | 19 | |
| 18 | 2022 | 18 | |
| 19 | 2023 | 18 | |
| 20 | 2015 | 12 |
About Yuji Eso
Yuji Eso is a scholar working on Hepatology, Oncology, Cancer Research, Epidemiology and Pathology and Forensic Medicine, having authored 60 papers that have together received 960 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Liver Disease Diagnosis and Treatment (9 papers), Hepatitis C virus research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Cancer Genomics and Diagnostics (5 papers), Hepatitis B Virus Studies (5 papers) and Liver physiology and pathology (5 papers). The work is most often cited by research in Hepatology (417 citations), Cancer Research (148 citations), Oncology (250 citations), Pathology and Forensic Medicine (109 citations) and Epidemiology (185 citations). Yuji Eso has collaborated with scholars based in Japan and United States. Frequent co-authors include Hiroyuki Marusawa, Hiroshi Seno, Atsushi Takai, Haruhiko Takeda, Takahiro Shimizu, Ken Takahashi, Kojiro Taura, Tsutomu Chiba, Yoshihide Ueda and Shigeharu Nakano. Their work appears in journals such as Hepatology Research, Journal of Gastroenterology, Journal of Gastroenterology and Hepatology, Cancers and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.